
Neuralink — Pioneering Brain Computer Interfaces
In our clinical trials, people are using Neuralink devices to control computers and robotic arms with their thoughts. This technology will restore autonomy to those with unmet medical needs …
PRIME Study Progress Update | Updates | Neuralink
Apr 12, 2024 · An exploded view of the N1 Implant. Signals acquired by the electrodes are routed to electronics contained in the enclosure of the N1 Implant, which process and wirelessly …
Updates - Neuralink
Jun 2, 2025 · Neuralink is developing a fully-implanted, wireless, high-channel count, brain-computer interface (BCI) with the goal of enabling people with paralysis to directly use their …
A Year of Telepathy | Updates | Neuralink
Feb 5, 2025 · In January 2024, Noland became the first person to receive a Neuralink implant. The implant, or Link, is our fully implantable, cosmetically invisible, wireless brain-computer …
Technology | Neuralink
Advanced, custom, low-power chips and electronics process neural signals, transmitting them wirelessly to the Neuralink Application, which decodes the data stream into actions and intents.
PRIME Study Progress Update — Second Participant - Neuralink …
Aug 21, 2024 · Last month, Alex,* the second participant in our PRIME Study,** received his Neuralink implant (Link). The surgery, conducted at the Barrow Neurological Institute, went …
PRIME Study Progress Update — User Experience | Updates
May 8, 2024 · We’ve just passed 100 days since the first participant in our clinical trial received his Neuralink implant. Read our latest progress update.
Neuralink’s First-in-Human Clinical Trial is Open for Recruitment
Sep 19, 2023 · Neuralink’s First-in-Human Clinical Trial is Open for Recruitment We are happy to announce that we’ve received approval from the reviewing independent institutional review …
Careers - Neuralink
Discover your future at Neuralink, where we lead the development of cutting-edge brain-computer interfaces.
GB-PRIME Study Launch | Updates | Neuralink
Jul 31, 2025 · The clinical study is currently open to residents of Great Britain with limited or no ability to use both hands due to amyotrophic lateral sclerosis (ALS), spinal cord injury, or other …